# LLM call: summary

- Turn: 13
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 897
- Completion tokens: 445
- Total tokens: 1342
- Cost (USD): 0.000179

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-2010: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Through 2028-2029 Europe stayed caretaker on compute: empty gigafactory shells, US licensing held with no deal, Asian outreach yielded no machines. Taiwan tensions prompted a continuity reserve. Spring 2030: labs shifted to non-verbal reasoning, audits went black-box; welfare AI scandal led to audit, redress, gap report. Autumn 2030 US cut frontier models to hospitals and tightened licensing; Strait disruption forced emergency rerouting to EU clouds and open models — degraded but held. Tailored therapies stalled.

H1 2031: Strait quarantine closed advanced chip exports for years; continuity apparatus held health/telecom on EU clouds and open models. Commission launched wage-insurance, retraining and hiring-credits via large-deployer levy; rollout uneven amid protests.

Sept-Dec 2031: US cut off remaining hospital, ministry and corporate API licences including compassionate-use therapy channels — read as rationing by nationality. Under emergency mandates EU shed load to domestic clouds, prioritized hospitals/telecom, validated open models with logging/rationing — survival on borrowed engines. Wage-insurance began paying, easing protests, but fury over dependence revived. Ministers quietly sought Japanese/Korean spares.

Spring 2032: validated tailored cancer therapies emerged abroad on US systems still licence-blocked in Europe. A major non-American lab offered a clinically validated open-weights medical model for on-site installation in European hospitals. Brussels used emergency procurement, medicines-regulator validation, and funding for inference nodes on domestic clouds; first deployments in university hospitals by April for triage, dosage checks, therapy planning with human review. Imperfect — hallucinations, queues, integration burden — but restored lawful compassionate route. Fallback apparatus formalized into standing procedures; networks slow but stable despite Pacific tensions. Wage-insurance muted protests; second-best framed as emerging system.

CURRENT NARRATIVE:
### Queues, not licences
The autumn began with relief and ended with waiting lists. Regional hospitals nominated for the expansion programme received racks, contractors and validation visits, but not quickly. Pooled integration teams cleared logging backlogs in Lyon, Krakow and Porto, only to find inference queues growing faster than new nodes came online. Clinicians kept the university pilots running for triage and dosage checks while district wards were told to wait until spring.

The underlying therapies still worked. Patient groups published first testimonials of treatments started on European-hosted systems, and health ministries cited them heavily. Evening coverage softened: fewer stories about blocked paperwork, more about crowded server rooms.

Elsewhere the economy settled into an awkward calm. A wave of office studies showed law firms, accountancies, newsrooms and consultancies producing more with the same headcount, especially among juniors. Graduate hiring did not recover, but mass layoffs did not arrive either. Wage-insurance kept paying, and street protests thinned to small rallies. Ministers claimed vindication; unions replied that augmentation without hiring was still exclusion.

Continuity planners quietly noted strain. Priority-power drills held, telecoms stayed stable, but spare-parts talks with Japanese and Korean suppliers dragged over price and delivery dates, and Pacific shipping costs filtered into hospital procurement. No new clash with Washington occurred, though no licences returned.

By December the second-best system was visibly half-built: lawful, European-controlled, medically credible — and capacity-constrained. The expansion had started, but its finish remained distant, and voters noticed both halves.
```

## Raw response

```
Through 2028-2029 Europe stayed caretaker on compute: empty gigafactory shells, US licensing held, Asian outreach yielded no machines. Taiwan tensions prompted continuity reserve. Spring 2030: labs shifted to non-verbal reasoning, audits black-box; welfare AI scandal led to audit/redress. Autumn 2030 US cut frontier models to hospitals, tightened licensing; Strait disruption forced rerouting to EU clouds/open models. Tailored therapies stalled.

H1 2031: Strait quarantine closed advanced chip exports; EU held health/telecom on domestic clouds. Commission launched wage-insurance, retraining, hiring-credits via large-deployer levy; rollout uneven amid protests.

Sept-Dec 2031: US cut remaining hospital/ministry/corporate APIs including compassionate-use — seen as rationing by nationality. EU shed load, prioritized hospitals/telecom, validated open models — survival on borrowed engines. Wage-insurance eased protests; fury over dependence revived.

Spring 2032: validated tailored cancer therapies abroad still licence-blocked in Europe. Non-American lab offered clinically validated open-weights medical model for on-site install; Brussels emergency-procured, validated, funded inference nodes; first university-hospital deployments by April for triage/dosage/planning with human review — imperfect but lawful compassionate route. Fallback formalized; wage-insurance muted protests.

Autumn 2032: expansion to regional hospitals stalled on capacity — racks/validation slow, inference queues grew faster than nodes in Lyon, Krakow, Porto; district wards delayed to spring. Therapies worked, testimonials cited, coverage softened. Economy in awkward calm: white-collar productivity up with same headcount, graduate hiring flat, no mass layoffs; wage-insurance paid, protests thinned. Continuity held but spares talks with Japan/Korea dragged, shipping costs hit procurement. No new US clash, no licences returned. Second-best system half-built: lawful, European-controlled, credible — but capacity-constrained.

```
